Clinical Trial Update: Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on adjuvant treatment with apatinib for nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Wei Jiang | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN